These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3760382)

  • 1. Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients.
    Strashun AM; Goldsmith SJ; Horowitz SF
    J Am Coll Cardiol; 1986 Nov; 8(5):1082-7. PubMed ID: 3760382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
    Schwartz RG; McKenzie WB; Alexander J; Sager P; D'Souza A; Manatunga A; Schwartz PE; Berger HJ; Setaro J; Surkin L
    Am J Med; 1987 Jun; 82(6):1109-18. PubMed ID: 3605130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
    Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
    Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance.
    Choi BW; Berger HJ; Schwartz PE; Alexander J; Wackers FJ; Gottschalk A; Zaret BL
    Am Heart J; 1983 Oct; 106(4 Pt 1):638-43. PubMed ID: 6613807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
    Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
    Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.
    Mitani I; Jain D; Joska TM; Burtness B; Zaret BL
    J Nucl Cardiol; 2003; 10(2):132-9. PubMed ID: 12673177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value.
    Skubitz KM; Blaes AH; Konety SH; Francis GS
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):787-798. PubMed ID: 28856562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy.
    Shureiqi I; Cantor SB; Lippman SM; Brenner DE; Chernew ME; Fendrick AM
    Br J Cancer; 2002 Jan; 86(2):226-32. PubMed ID: 11870511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of doxorubicin-induced cardiomyopathy resulting from postsurgical adjuvant treatment of patients with soft tissue sarcomas.
    Dresdale A; Bonow RO; Wesley R; Palmeri ST; Barr L; Mathison D; D'Angelo T; Rosenberg SA
    Cancer; 1983 Jul; 52(1):51-60. PubMed ID: 6850545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective right ventricular dysfunction following doxorubicin therapy.
    Sperber AD; Cantor AA; Biran H; Keynan A
    Isr J Med Sci; 1987 Aug; 23(8):896-9. PubMed ID: 3679793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography.
    Palmeri ST; Bonow RO; Myers CE; Seipp C; Jenkins J; Green MV; Bacharach SL; Rosenberg SA
    Am J Cardiol; 1986 Sep; 58(7):607-13. PubMed ID: 3751931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the left ventricular ejection fraction response to doxorubicin using a multiple linear regression model.
    Rabinovitch M; Suissa S; Stern J; Adam J; Mettauer B; Boileau G; Elstein J; Rouleau J
    Can J Cardiol; 1989; 5(8):382-8. PubMed ID: 2605548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive monitoring of cardiac hemodynamic parameters in doxorubicin-treated patients: comparison with echocardiography.
    Villani F; Meazza R; Materazzo C
    Anticancer Res; 2006; 26(1B):797-801. PubMed ID: 16739356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of early anthracycline cardiotoxicity by monitoring the peak filling rate.
    Ganz WI; Sridhar KS; Forness TJ
    Am J Clin Oncol; 1993 Apr; 16(2):109-12. PubMed ID: 8452100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: role of radionuclide cardiac angiography.
    Agarwala S; Kumar R; Bhatnagar V; Bajpai M; Gupta DK; Mitra DK
    J Pediatr Surg; 2000 Dec; 35(12):1786-9. PubMed ID: 11101737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide ejection fraction in doxorubicin cardiotoxicity.
    Morgan GW; McIlveen BM; Freedman A; Murray IP
    Cancer Treat Rep; 1981; 65(7-8):629-38. PubMed ID: 7248982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography.
    Fatima N; Zaman MU; Hashmi A; Kamal S; Hameed A
    Nucl Med Commun; 2011 May; 32(5):381-5. PubMed ID: 21346663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.